Publication | Open Access
Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved N-Acetylgalactosamine–Conjugated RNA Interference Therapeutic
39
Citations
14
References
2021
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1